NEVVI Medicare utilization intelligence

← back

BANNEN, PAULMD NPI 1942392899 Clinician

Medical Oncology · OLNEY, MD

Specialty Medical Oncology — from billed Medicare claims
Trained UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 30 years since medical school (class of 1996, self-reported to CMS)
Location OLNEY, MD · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 50 codes billed · 115,642 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026
MARYLAND ONCOLOGY HEMATOLOGY PA
2026
RCCA MD LLC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2010-12

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J1453 Injection, fosaprepitant, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1100 Injection, dexamethasone sodium phosphate, 1 mg
80053 Blood test, comprehensive group of blood chemicals
J0897 Injection, denosumab, 1 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J1437 Injection, ferric derisomaltose, 10 mg
J3475 Injection, magnesium sulfate, per 500 mg
96372 Injection of drug or substance under skin or into muscle
83735 Magnesium level
84100 Phosphate level
83540 Iron level
83550 Iron binding capacity
96375 Injection of additional new drug or substance into vein
82728 Ferritin (blood protein) level
83615 Lactate dehydrogenase (enzyme) level
J3490 Unclassified drugs
96413 Administration of chemotherapy into vein, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96160 Administration and interpretation of patient-focused health risk assessment
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
J3480 Injection, potassium chloride, per 2 meq
J1200 Injection, diphenhydramine hcl, up to 50 mg
82232 Beta-2 microglobulin (protein) level
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
82746 Folic acid level, serum
96361 Infusion into a vein for hydration, each additional hour
82607 Cyanocobalamin (vitamin b-12) level
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J3489 Injection, zoledronic acid, 1 mg
96415 Administration of chemotherapy into vein, each additional hour
82248 Bilirubin level, direct
99195 Drawing of blood for a medical problem
96360 Infusion into a vein for hydration, 31-60 minutes
82306 Vitamin d-3 level
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96417 Administration of additional new drug or substance into vein, 1 hour or less
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
36415 Insertion of needle into vein for collection of blood sample
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
38222 Biopsy and aspiration of bone marrow sample for diagnosis

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.